Intellectus Partners’s Bristol-Myers Squibb BMY Stock Holding History

Intellectus Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.14M	Buy	18,796 +8	+0%	+$466	0.23%	120
2025 Q4	$1.01M	Sell	18,788 -392	-2%	-$18.9K	0.2%	133
2025 Q3	$865K	Sell	19,180 -7,092	-27%	-$331K	0.17%	149
2025 Q2	$1.22M	Sell	26,272 -682	-3%	-$33.5K	0.26%	106
2025 Q1	$1.64M	Sell	26,954 -1,544	-5%	-$90K	0.41%	71
2024 Q4	$1.61M	Sell	28,498 -1,494	-5%	-$83.5K	0.36%	76
2024 Q3	$1.55M	Sell	29,992 -1,343	-4%	-$63K	0.4%	74
2024 Q2	$1.3M	Sell	31,335 -6,253	-17%	-$280K	0.36%	78
2024 Q1	$2.04M	Sell	37,588 -138	-0.4%	-$7.03K	0.54%	52
2023 Q4	$1.94M	Buy	37,726 +574	+2%	+$30.1K	0.56%	51
2023 Q3	$2.16M	Sell	37,152 -935	-2%	-$57.3K	0.68%	41
2023 Q2	$2.44M	Sell	38,087 -679	-2%	-$45.5K	0.73%	36
2023 Q1	$2.69M	Sell	38,766 -180	-0.5%	-$12.7K	0.85%	32
2022 Q4	$2.8M	Sell	38,946 -223	-0.6%	-$16.8K	0.98%	24
2022 Q3	$2.79M	Buy	39,169 +4,062	+12%	+$295K	0.99%	21
2022 Q2	$2.72M	Sell	35,107 -1,055	-3%	-$80.3K	0.94%	24
2022 Q1	$2.66M	Buy	36,162 +4,749	+15%	+$319K	0.79%	33
2021 Q4	$1.96M	Sell	31,413 -1,113	-3%	-$65.3K	0.5%	50
2021 Q3	$1.94M	Sell	32,526 -887	-3%	-$58.4K	0.47%	52
2021 Q2	$2.23M	Buy	33,413 +1,773	+6%	+$116K	0.5%	49
2021 Q1	$2.01M	Buy	31,640 +744	+2%	+$46.3K	0.55%	47
2020 Q4	$1.93M	Buy	30,896 +81	+0.3%	+$4.98K	0.58%	44
2020 Q3	$1.86M	Buy	30,815 +3,638	+13%	+$219K	0.7%	32
2020 Q2	$1.6M	Sell	27,177 -3,228	-11%	-$193K	0.62%	40
2020 Q1	$1.7M	Sell	30,405 -2,473	-8%	-$151K	0.81%	28
2019 Q4	$2.11M	Buy	32,878 +19,878	+153%	+$1.14M	0.86%	29
2019 Q3	$659K	Buy	13,000 +505	+4%	+$23.7K	0.29%	109
2019 Q2	$567K	Buy	12,495 +11,883	+1,942%	+$554K	0.25%	126
2019 Q1	$29K	Hold	612	–	–	0.01%	289
2018 Q4	$32K	Sell	612 -3,383	-85%	-$182K	0.02%	166
2018 Q3	$248K	Buy	3,995 +112	+3%	+$6.65K	0.09%	214
2018 Q2	$215K	Hold	3,883	–	–	0.08%	217
2018 Q1	$246K	Hold	3,883	–	–	0.08%	212
2017 Q4	$238K	Sell	3,883 -80	-2%	-$5K	0.09%	207
2017 Q3	$253K	Hold	3,963	–	–	0.1%	196
2017 Q2	$221K	Buy	3,963 +80	+2%	+$4.35K	0.1%	188
2017 Q1	$211K	Hold	3,883	–	–	0.11%	179
2016 Q4	$227K	Buy	+3,883	New	+$212K	0.12%	163

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Intellectus Partners's BMY Position: Q1 2026 in Review

Intellectus Partners increased its Bristol-Myers Squibb (BMY) stake by 0.04% in Q1 2026, buying an estimated $466 and bringing the position to 18,796 shares worth $1.14M. The position accounts for 0.23% of the portfolio, ranked #120.

Intellectus Partners first reported a position in BMY in Q4 2016 and has held it in 38 quarters since. The position peaked at $2.8M in Q4 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Intellectus Partners held 18,796 shares of Bristol-Myers Squibb worth $1.14M as of Q1 2026.
Intellectus Partners bought 8 Bristol-Myers Squibb shares in Q1 2026, an estimated $466.
Bristol-Myers Squibb made up 0.23% of Intellectus Partners's portfolio in Q1 2026, its #120 holding.
Intellectus Partners first reported a position in Bristol-Myers Squibb in Q4 2016 and has held it in 38 quarters since.
Intellectus Partners's Bristol-Myers Squibb position peaked at $2.8M in Q4 2022.
2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Intellectus Partners's 13F filing for Q1 2026, filed 10 Apr 2026.